Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults.
about
Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-AnalysisDoes vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms.Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in GhanaAssociations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin.Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndromeVitamin D deficiency and risk for cardiovascular disease.Childhood obesity and adult morbidities.Vitamin D deficiency and insulin resistance in obese African-American adolescentsAssociation of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetesPlasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.Vitamin D deficiency in women with polycystic ovary syndromeSerum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents.Circulating 25-hydroxyvitamin D is associated with insulin resistance cross-sectionally but not longitudinally in older adults: The Cardiovascular Health StudyAssociation of dietary vitamin D, serum 25-hydroxyvitamin D, insulin-like growth factor-1 concentrations and components of metabolic syndrome among Iranian women.The study of serum vitamin d and insulin resistance in chinese populations with normal glucose tolerance.Lack of association between 25(OH)D levels and incident type 2 diabetes in older women.Vitamin D deficiency and risk of cardiovascular disease.Vitamin D insufficiency and insulin resistance in obese adolescents.Vitamin D deficiency in chronic liver disease.Effect of therapeutic dose of vitamin d on serum adiponectin and glycemia in vitamin d-insufficient or deficient type 2 diabetic patients.The relationship between serum 25-hydroxyvitamin D concentration, cardiorespiratory fitness, and insulin resistance in Japanese men.The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults.Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adultsIs vitamin d deficiency a new risk factor for cardiovascular disease?Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the Sun Exposure and Vitamin D Supplementation (SEDS) Study.Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique.Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study.Relationship between serum 25-hydroxyvitamin D and lower extremity arterial disease in type 2 diabetes mellitus patients and the analysis of the intervention of vitamin D.Association of 25-hydroxy Vitamin D levels with indexes of general and abdominal obesity in Iranian adolescents: The CASPIAN-III study.Vitamin D and hyperparathyroidism in obesity.Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men.The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial.Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysisImpact of vitamin D deficiency on maternal and birth outcomes in the Saudi population: a cross-sectional study.The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome.
P2860
Q26824831-62A56771-3964-42DD-9E4F-375280D25E09Q33557423-44862DC6-D0B5-4EAF-9F3D-D61FF9CDAD2AQ33579559-B513E1A6-5D76-407D-929D-A4EA8B26FDF8Q33602257-C4774245-A061-495D-823F-271DB0D8C556Q33749318-16364A1E-1AA1-47AB-9A56-5BCFEA65C6B9Q33751630-6D023E30-99C2-4722-BEF3-52A9F6819C64Q33775793-25214BF5-DF56-4742-B906-35E2DC739AE3Q33790604-965CCAF1-42D3-46ED-83D2-6D60FBBBF08DQ33814185-5056DD89-F0DE-441A-9FC1-61F31B876DB4Q33873226-FCB5BB3A-9DC4-4B74-A1DF-6E46CF6CD1F4Q33881452-479B2CDB-BFD3-41D4-B018-3E6B85B6D89AQ33917108-DFFEDE2F-0802-424D-8537-9DB54FC24C8AQ33966808-902A12B8-8CB2-4407-B12D-37B8E6D128C2Q34155415-DE9B6416-8F3E-4672-B258-E9C4936DC9A7Q34169969-143C2A22-DC93-4488-9523-5B23DBE9794DQ34183241-EAD6A8FF-86C7-4EE4-B8C1-89FD400E50ADQ34583291-25875C19-FBA2-4030-8D77-0A0F4E316A75Q34586829-23891C59-4A1F-4E33-B3AC-57F749BF662FQ34642797-0A5AA067-DAF9-4B6E-964A-73DDC212323CQ34728285-303FEC80-7557-4AC3-8870-DF4CA92EC4F3Q34733598-FBD38C02-F00B-4F83-85A4-52900DF95C07Q35003735-AC706F4E-135D-49BE-8A73-DA2C6BBD33FCQ35013570-F7D71204-C0F7-4361-9F99-4FC894291141Q35018209-CCF3DB7B-8CBA-4AD6-9A19-55D9868927C9Q35080436-347CE6BE-0511-44DB-AF4E-B0CE8BAE7FE6Q35125338-711649C1-6A71-43D7-BB9C-D02AD70317E9Q35193436-92F91596-1599-4993-B31D-FF63D900B550Q35338166-1E361381-E592-43F1-AA27-573CD37F8BC3Q35339508-E175082A-E4C2-45E0-BB0F-145AA5999084Q35405187-7249EC87-43A8-4F0F-9D1C-189C4AC471D9Q35405441-41A8B56F-ED57-41BE-838C-EF3BF18A358EQ35422142-7B241388-C144-4B56-8533-557A3D81DBA3Q35454563-0DF80EEC-711D-4FAF-B8B5-6894944E183FQ35468562-FFD39220-DC72-44E9-9FF5-29D9FA5AB556Q35764905-905195CC-9C9D-45A1-8BEA-1E0FF206CDFBQ35791100-20416FF2-17D3-4A27-A852-CD20043FD8C6Q35923664-EF0DC273-ABD2-4FCD-8E07-759AA7A517FFQ36014472-385844B6-9DE5-472C-B259-13A1FAC74059Q36028624-508DA82F-BEDD-4D4D-9341-215D045ABEF3Q36105683-5543D921-21B0-4F87-A764-A45CBBD64AEB
P2860
Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@en
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@nl
type
label
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@en
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@nl
prefLabel
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@en
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@nl
P2093
P2860
P356
P1433
P1476
Plasma 25-hydroxyvitamin d is ...... enotype in nondiabetic adults.
@en
P2093
Anastassios G Pittas
Christina D Economos
Nicola M McKeown
Paul F Jacques
Sarah L Booth
P2860
P304
P356
10.3945/JN.108.093831
P407
P577
2008-12-23T00:00:00Z